Topics

POISED Study Supports Risk of Cessation of Oral Immunotherapy for Peanut Allergy; PACE Study ...

05:00 EST 7 Nov 2019 | BioMedReports - Blog

New York, Nov. 07, 2019 (GLOBE NEWSWIRE)

Read more...

Original Article: POISED Study Supports Risk of Cessation of Oral Immunotherapy for Peanut Allergy; PACE Study ...

NEXT ARTICLE

More From BioPortfolio on "POISED Study Supports Risk of Cessation of Oral Immunotherapy for Peanut Allergy; PACE Study ..."

Quick Search